BYSI · BeyondSpring Inc
United States · RS rating 4 · As of 2026-10-14
| Price | 0.59 USD |
|---|---|
| 1-day change | -3.2% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 10 / 4 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 17 / 12 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +75.0% |
| Market cap (USD) | $68.3M |